Mucinoses

Results: 83



#Item
1PRESS RELEASE Genkyotex’s GKT137831 Granted Orphan Drug Designation in the US and EU for the Treatment of Systemic Sclerosis Geneva, Switzerland, and Archamps, France, 11th November, 2015 – Genkyotex, the leading de

PRESS RELEASE Genkyotex’s GKT137831 Granted Orphan Drug Designation in the US and EU for the Treatment of Systemic Sclerosis Geneva, Switzerland, and Archamps, France, 11th November, 2015 – Genkyotex, the leading de

Add to Reading List

Source URL: www.biomedvc.com

Language: English - Date: 2015-11-12 02:47:43
2Technology Opportunity, Ref. No. UZNovel Pharmacological Treatment of Scleroderma This invention relates to a novel pharmacological treatment of scleroderma comprising the administration of miR-29.

Technology Opportunity, Ref. No. UZNovel Pharmacological Treatment of Scleroderma This invention relates to a novel pharmacological treatment of scleroderma comprising the administration of miR-29.

Add to Reading List

Source URL: www.switt.ch

Language: English - Date: 2014-02-01 16:20:50
3Privacy Policy* April, 2015 The Scleroderma Society of Canada is committed to protecting the privacy of the personal information of its employees, volunteers, members, customers, donors and other stakeholders. We value t

Privacy Policy* April, 2015 The Scleroderma Society of Canada is committed to protecting the privacy of the personal information of its employees, volunteers, members, customers, donors and other stakeholders. We value t

Add to Reading List

Source URL: www.scleroderma.ca

Language: English - Date: 2015-04-09 17:32:17
4Soluble CD90 as biomarker of pulmonary complications in Systemic Sclerosis A new serological two-staged biomarker of pulmonaryarterial hypertension and pulmonary fibrosis Subtitle Technology

Soluble CD90 as biomarker of pulmonary complications in Systemic Sclerosis A new serological two-staged biomarker of pulmonaryarterial hypertension and pulmonary fibrosis Subtitle Technology

Add to Reading List

Source URL: www.campus-technologies.de

Language: English - Date: 2015-02-19 09:34:47
5Microsoft Word - Ad for Recruitment for Survey26_FINAL.docx

Microsoft Word - Ad for Recruitment for Survey26_FINAL.docx

Add to Reading List

Source URL: www.scleroderma.ca

Language: English - Date: 2015-05-04 18:53:56
6Science / Methodology / Evaluation / Mucinoses / Scleroderma / Questionnaire

DOC Document

Add to Reading List

Source URL: arthritis-research.com

Language: English
7ARTHRITIS INFORMATION SHEET Scleroderma This sheet has been written for people affected by scleroderma. It provides general

ARTHRITIS INFORMATION SHEET Scleroderma This sheet has been written for people affected by scleroderma. It provides general

Add to Reading List

Source URL: www.arthritiswa.org.au

Language: English - Date: 2012-04-09 23:00:14
8Understanding Scleroderma Seminar Convenor: Dr Jane Zochling When: Saturday 22nd November 2014 Time: 10.00 am Registration[removed]am Start) to 4.00 p.m. Where: The Grange, 87 High Street, Campbell Town, Tasmania Cost:

Understanding Scleroderma Seminar Convenor: Dr Jane Zochling When: Saturday 22nd November 2014 Time: 10.00 am Registration[removed]am Start) to 4.00 p.m. Where: The Grange, 87 High Street, Campbell Town, Tasmania Cost:

Add to Reading List

Source URL: www.sclerodermaaustralia.com.au

Language: English - Date: 2014-10-28 18:56:03
9ARTHRITIS INFORMATION SHEET ARTHRITIS

ARTHRITIS INFORMATION SHEET ARTHRITIS

Add to Reading List

Source URL: www.arthritisaustralia.com.au

Language: English - Date: 2015-03-12 23:37:49
10Erythrocyte glutathione transferase: a non-antibody biomarker for systemic sclerosis, which correlates with severity and activity of the disease

Erythrocyte glutathione transferase: a non-antibody biomarker for systemic sclerosis, which correlates with severity and activity of the disease

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2013-07-25 09:54:49